EGFR and non-small cell lung carcinoma: These mutations are localized in exons 18–21 of the EGFR gene and have a prevalence of around 10%–20% in Caucasians with NSCLC adenocarcinomas, and approximately 40%–50% in Asians.1, 2, 3, 4